Verena Kopfnagel

Verena Kopfnagel

Auto-generated profile, based on publicly available information

Verena Kopfnagel

Division of Immunodermatology and Allergy Research Department of Dermatology and Allergy Hannover Medical School Hannover Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VKVerena Kopfnagel
Verena Kopfnagel
SWSylvia Wagenknecht
Sylvia Wagenknecht
JHJürgen Harder
Jürgen Harder
KHKarsten Hofmann
Karsten Hofmann
MKMichael Kleine
Michael Kleine
TWThomas Werfel
Thomas Werfel

1 October 2013 in Current Opinion in Allergy and Clinical Immunology
Verified
Journal Article
Closed access
VKVerena Kopfnagel
Verena Kopfnagel
JHJürgen Harder
Jürgen Harder
TWThomas Werfel
Thomas Werfel
To summarize the findings on the expression of antimicrobial peptides in the skin in inflammatory skin diseases and particularly in atopic dermatitis. Moreover, the literature addressing the functions of antimicrobial peptides (AMPs) beyond antimicrobial activities with impact on allergic skin inflammation is summarized as well. Although lower expressed than in psoriasis, most AMPs have been shown to be either constitutively expressed or upregulated in atopic dermatitis as well. A number of immunoregulatory functions which might impact on allergic skin inflammation have been described for several antimicrobial peptides, mainly for human β-defensins and the cathelicidin LL-37. From the recent literature, there is considerable evidence that AMPs are induced in the skin in atopic dermatitis. However, some studies suggest that the induction, release or mobilization of some AMPs in atopic dermatitis may not reach sufficient levels to provide adequate control of cutaneous microbial colonization. Th2 cytokines appear to negatively influence the expression and induction of some AMPs. A number of immunoregulatory functions have been described for several AMPs. Most of them point to a proinflammatory function of AMPs in addition to their antimicrobial activities. Further studies are needed to clarify the role of AMPs in atopic dermatitis.

21 June 2017 in Allergy
Verified
Journal Article
Closed access
PDF file
VKV. Kopfnagel
V. Kopfnagel
SWS. Wagenknecht
S. Wagenknecht
LBL. Brand
L. Brand
JZJ. Zeitvogel
J. Zeitvogel
JHJ. Harder
J. Harder
TWT. Werfel
T. Werfel

2 December 2019 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
NHNiko Hensel
Niko Hensel
VRVerena Raker
Verena Raker
BFBenjamin Förthmann
Benjamin Förthmann
NDNora Tula Detering
Nora Tula Detering
SKSabrina Kubinski
Sabrina Kubinski
Peter ClausPeter Claus
Peter Claus
Background: Herpes simplex virus-1 (HSV-1) infections of the central nervous system (CNS) can result in HSV-1 encephalitis (HSE) which is characterized by severe brain damage and long-term disabilities. Different cell types including neurons and astrocytes become infected in the course of an HSE which leads to an activation of glial cells. Activated glial cells change their neurotrophic factor profile and modulate inflammation and repair. The superfamily of fibroblast growth factors (FGFs) is one of the largest family of neurotrophic factors comprising 22 ligands. FGFs induce pro-survival signaling in neurons and an anti-inflammatory answer in glial cells thereby providing a coordinated tissue response which favors repair over inflammation. Here, we hypothesize that FGF expression is altered in HSV-1-infected CNS cells. Method: We employed primary murine cortical cultures comprising a mixed cell population of astrocytes, neurons, microglia, and oligodendrocytes. Astrocyte reactivity was morphometrically monitored by an automated image analysis algorithm as well as by analyses of A1/A2 marker expression. Altered FGF expression was detected by quantitative real-time PCR and its paracrine FGF activity. In addition, HSV-1 mutants were employed to characterize viral factors important for FGF responses of infected host cells. Results: Astrocytes in HSV-1-infected cortical cultures were transiently activated and became hypertrophic and expressed both A1- and A2-markers. Consistently, a number of FGFs were transiently upregulated inducing paracrine neurotrophic signaling in neighboring cells. Most prominently, FGF-4, FGF-8, FGF-9, and FGF-15 became upregulated in a switch-on like mechanism. This effect was specific for CNS cells and for a fully functional HSV-1. Moreover, the viral protein ICP0 critically mediated the FGF switch-on mechanism. Conclusions: HSV-1 uses the viral protein ICP0 for the induction of FGF-expression in CNS cells. Thus, we propose that HSV-1 triggers FGF activity in the CNS for a modulation of tissue response upon infection.

1 August 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VKVerena Kopfnagel
Verena Kopfnagel
SDSylvia Dreyer
Sylvia Dreyer
KBKathrin Baumert
Kathrin Baumert
MSMaximilian Stark
Maximilian Stark
JHJürgen Harder
Jürgen Harder
TWThomas Werfel
Thomas Werfel

27 June 2021 in Allergy
Verified
Journal Article
Open access
PDF file
VKVerena Kopfnagel
Verena Kopfnagel
SDSylvia Dreyer
Sylvia Dreyer
JZJana Zeitvogel
Jana Zeitvogel
DPDietmar H. Pieper
Dietmar H. Pieper
ABAnna Buch
Anna Buch
TWThomas Werfel
Thomas Werfel
Background: The high susceptibility of AD patients to microbial skin infections has been attributed to a deficient antimicrobial peptide (AMP) expression, which is contradicted by a growing amount of recent studies clearly demonstrating that AMP expression is not impaired in lesional skin of AD patients. The reasons for the high susceptibility of AD patients to microbial infections are still unknown.Methods: The influence of self‐DNA on the antimicrobial activity of RNase 7, LL‐37, and hBD2 has been investigated using antibacterial and antiviral assays. The amount of self‐DNA on skin has been analyzed by skin rinsings and subsequent quantification using dsDNA assays. DNA source was identified by qPCR.Results: Complex formation of the AMPs with self‐DNA significantly impaired their antibacterial activity againstStaphylococcus aureusand their antiviral activity againstHSV‐1. The inhibition of the antibacterial activity was dependent on the DNA concentration but not on the length of the DNA molecules. Of note, we detected significant higher amounts of cell‐free self‐DNA in skin rinses taken from lesional AD skin compared to skin rinses from non‐lesional skin and from normal skin of healthy donors. Consequently, rinse solution from AD lesional skin prevented antibacterial activity of LL‐37.Conclusion: Our study indicates that extracellular self‐DNA is released in considerable amounts in AD skin lesions and AMP‐self‐DNA‐complex formation leads to a significant loss of antibacterial and antiviral activity in atopic dermatitis. Studies on strategies to reduce the amount of extracellular DNA in AD are needed to identify possible methods relevant in clinical settings.